📢 Dexcom's Strategic Shift: Transforming Challenges into Opportunities Dexcom is laying off 535 employees in San Diego as it shifts manufacturing to Mesa, Arizona, and transforms its headquarters into an innovation hub. This strategic move reflects Dexcom's rapid growth and focus on enhancing its R&D capabilities. Despite the layoffs, the company plans to add 400 new positions in San Diego and expand its global footprint, including a new European site in Ireland. Dexcom's continuous glucose monitors continue to lead in the market, underscoring its commitment to innovation in diabetes management. 🔗 https://lnkd.in/gZJV6t_J #MedTech #Biotech #Innovation #DiabetesManagement #Dexcom #Manufacturing #JobOpportunities #R&D
Viltis’ Post
More Relevant Posts
-
🧐 Seeking opportunities to collaborate & grow your business in the global digital health arena? R2GConnect facilitates digital health #partnerships by connecting innovative #startups with key players like #Insurances, #Investors, #Pharma, #ServiceProviders, and more! Today, we bring to your attention a #briefing, a #deal, and a help #request! 💥 Seeking a #CommercialPartnership Opportunity? Dr. Reddy's Laboratories, a global #pharmaceutical company, is on the lookout for Health Tech Startups with #NonInvasive, #Wearable Devices for #DiseaseManagement Solutions! 📌 Learn more & Apply on R2GConnect.com: https://bit.ly/3UKOTOg 💥 Ignited Vision by Susanne Gruber offers a fantastic #deal for #Business #Model assessment for a Digital Health product. Deadline: May 20, 2024 📌 Grab the deal: https://bit.ly/4dh1wrn 💥 Vilimed, a medical technology company with 2 #medicaldevices in their portfolio, needs #support to #enter new #markets in Germany, UK, and France. Can you help? Deadline: May 15, 2024 📌 Offer your expertise: https://bit.ly/4dkZCWF Discover more collaboration opportunities & foster growth with R2GConnect.com!🌍 If you are curious about how you can best use the platform, book a demo session with Sorin STIRCU, Partnerships Manager: https://bit.ly/3TGL2kF #globalhealth #digitalheath #healthcare #specialoffers #opportunities
To view or add a comment, sign in
-
President - Government, Education, Infrastructure and Life Science Industries - JLL; Independent Real Estate Investor; Angel Investor/Advisor
Medical device companies: Choosing a site for a manufacturing facility is one of the most important business decisions leadership can make. Follow these tips to mitigate risks, save on operating costs, find the right talent and more. #JLLlifesciences #medtech #medicaldevices
How smart location choices can raise profits for your medtech company
us.jll.com
To view or add a comment, sign in
-
Medical device companies: Choosing a site for a manufacturing facility is one of the most important business decisions leadership can make. Follow these tips to mitigate risks, save on operating costs, find the right talent and more. #JLLlifesciences #medtech #medicaldevices
How smart location choices can raise profits for your medtech company
us.jll.com
To view or add a comment, sign in
-
Medical device companies: Choosing a site for a manufacturing facility is one of the most important business decisions leadership can make. Follow these tips to mitigate risks, save on operating costs, find the right talent and more. #JLLlifesciences #medtech #medicaldevices
How smart location choices can raise profits for your medtech company
us.jll.com
To view or add a comment, sign in
-
Medical device companies: Choosing a site for a manufacturing facility is one of the most important business decisions leadership can make. Follow these tips to mitigate risks, save on operating costs, find the right talent and more. #JLLlifesciences #medtech #medicaldevices
How smart location choices can raise profits for your medtech company
us.jll.com
To view or add a comment, sign in
-
[Announcement] Premier Tech & MG Tech join expertise in the packaging industry Premier Tech and MG Tech Group are pleased to announce a strategic and promising partnership that will shape the future of both companies. Drawing on their respective expertise, they will meet the evolving needs of manufacturers — in the nutrition, industrial, fast-moving consumer goods and parapharmacy industry — for packaging technologies with high-performance and innovative solutions. The addition of Premier Tech to MG Tech’s capital will allow the French group to fully leverage the global ecosystem of Premier Tech Systems and Automation and access an extensive network of products, services and technologies to support its growth in the American and international markets. It will also allow Premier Tech to expand its technological platform portfolio as well as its North American and global offer, while strengthening its European footprint. For further information about this partnership, please consult the official press release here: https://lnkd.in/e7Kgw-sn #robotics #packaging #manufacturers #PremierTech #MGTech #partnership
To view or add a comment, sign in
-
🚀 Funding Strategist | | Angel Investor | Connector | Weekly Insights to help starts ups raise investment👇
👊Building a hardware start up and raising investment❓ Annual U.S. investment data on start ups creating tangible products. shows that in 2019, they represented 16.7% of the total priced rounds in "hard" start-ups. Data comprises: Biotech, Hardware, Energy, and Medical Device sectors. Last year that rose to 34.4% and the trend upwards is continuing in 2024 stateside. #hardware #innovation #data #raisingcapital #newableadvice
To view or add a comment, sign in
-
75% of MedTech and HealthTech Businesses Fail Assuming that the technology is sound, 75% of business failures are caused by either poor market understanding, or the inability to manufacture quality products in a timely manner. Therefore, good reproducible technology is only one of several critical elements required for successful commercialization. As indicated above, marketing and manufacturing are additional elements that are not only required, but required early in the product-development cycle. Several other elements are important to the implementation process, including funding, sales, manufacturing engineering, and the team itself. In many ways commercialization is like a political campaign: the engine is often the funding that drives the product toward a successful conclusion. Sometimes the market input will drive the technology. Often, as technology evolves, market input is needed early in the evolution process to adjust to market needs. Funding allows the technology to be developed, the market input to be generated, and the sales and manufacturing structure to be devised and implemented. Many companies start on a shoestring budget with little or no initial funding. We hear of fantastic successes when these companies rise to great heights from very humble beginnings. However, the vast number of companies that fall by the wayside is often played down. The takeaway here is that thinking about commercialization very early during the process of product formation significantly increases the probability of successful market entry, where a key element of success is getting the proper funding. Having a comprehensive plan and an understanding and commitment to commercialization concepts significantly reduces the risk for the investor. by D. Krohn #sales #commercialization #business #medtech #healthtech #himms
To view or add a comment, sign in
-
CEO @ Medical Funding Professionals, a Registered Investment Advisory Firm - Capital planning for Reg A+, Reg D (506c & 506b), State 504, S-1 for IPO's, VC, Private Equity, Hedge Funds, Family Offices
Wall Street analysts tipped 2024 as the year that medtech dealmaking would return after a two-year slowdown when companies were forced to navigate a tough economic environment, complicated by the COVID-19 pandemic still pressuring businesses. The first months of the year saw a steady pace of dealmaking but lacked many big-name, billion-dollar offers. However, Johnson & Johnson shook up the medtech M&A market in early April with its $13.1 billion proposal to buy Shockwave Medical. J&J’s offer — its second since late 2022 to top $10 billion — is the largest of the year so far, supplanting Boston Scientific’s $3.7 billion plan to buy Axonics.
J&J’s $13.1B Shockwave buy tops medtech M&A list in 2024
medtechdive.com
To view or add a comment, sign in
-
People - The Power of a Peak Performance Team 🌠In the Pharma and Medical Devices industry, a successful product launch begins with the PEOPLE. At ConnectA, we focus on harnessing the full potential of teams, ensuring they operate at peak performance with the right mindset. High-performing teams are crucial for bringing life-changing products to market. 🧠💪 Effective teamwork involves clear communication, collaboration, and a shared vision. By fostering a culture of excellence and continuous improvement, teams can overcome challenges and innovate effectively. We believe that the right people, working together with a common goal, can achieve remarkable results. In the coming weeks, we’ll share more insights on how teamwork and a high-performance mindset drive success. Stay tuned for more stories and tips! 🌟 #Pharma #MedicalDevices #ProductLaunch #TeamSuccess #PeakPerformance #Innovation
To view or add a comment, sign in
9,295 followers